Previous Article | Next Article 
Molecular and Cellular Biology, December 1999, p. 8526-8535, Vol. 19, No. 12
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
The Zinc Finger-Associated SCAN Box Is a Conserved
Oligomerization Domain
Amy J.
Williams,
Stephen C.
Blacklow, and
Tucker
Collins*
Department of Pathology, Brigham and Women's
Hospital, Boston, Massachusetts 02115
Received 14 July 1999/Returned for modification 8 August
1999/Accepted 27 August 1999
 |
ABSTRACT |
A number of Cys2His2 zinc finger proteins
contain a highly conserved amino-terminal motif termed the SCAN domain.
This element is an 80-residue, leucine-rich region that contains three
segments strongly predicted to be
-helices. In this report, we show
that the SCAN motif functions as an oligomerization domain mediating self-association or association with other proteins bearing SCAN domains. These findings suggest that the SCAN domain plays an important
role in the assembly and function of this newly defined subclass of
transcriptional regulators.
 |
INTRODUCTION |
Transcription factors frequently
consist of modular elements that include a DNA-binding domain and one
or more separable effector domains that may activate or repress
transcriptional initiation (for a review, see reference
37). Although the majority of the conserved sequence
motifs identified in transcription factors are associated with DNA
binding, many transcription factors also contain extended motifs that
mediate oligomerization to create an active complex. For example, in
transcription factors that bind DNA as a dimer, the leucine zipper and
helix-loop-helix motifs serve as dimerization domains and increase the
potential for functional variation (for a review, see reference
27). In other transcription factors, such as heat
shock factor, trimerization is required for specific DNA binding and is
controlled by a coiled-coil oligomerization domain (33).
Structural modules within transcription factors can regulate
subcellular localization, DNA binding, and gene expression by mediating
selective association of the transcription factors with each other or
with other cellular components.
A variety of modular sequence motifs accompany zinc finger elements in
the zinc finger family of transcription factors (20). These
motifs include the Kruppel-associated box (KRAB); the finger-associated box (FAX), found in a large number of Xenopus zinc finger
proteins; the poxvirus and zinc finger (POZ) domain, also known as the
BTB domain (Broad-Complex, Tramtrack, and Bric-a-brac); and the SCAN box or leucine-rich region (LeR). These conserved domains have functions that are important in the regulation of the
transcription factors.
KRAB is a conserved amino acid sequence motif at the amino-terminal end
of proteins that contain multiple Cys2-His2
(C2H2) zinc fingers at their carboxy termini
(4). The KRAB domain is found in almost one-third of the 300 to 700 genes encoding C2H2 zinc fingers. The
KRAB domain itself spans approximately 75 amino acids (aa), is divided
into A and B boxes, and is predicted to contain two charged amphipathic
helices (4). The KRAB domain functions to repress
transcription (26, 32, 39, 41) by recruiting the
transcriptional corepressor KRAB-associated protein-1 (12)
or the KRAB-A interacting protein (19). KRAB-containing zinc
finger proteins are likely to play a regulatory role during development.
A second zinc finger-associated protein-protein interaction motif
is the BTB or POZ domain. This is an evolutionarily conserved protein-protein interaction domain that is found at the N terminus of
C2H2-type zinc finger transcription factors and
in some proteins having a kelch motif (3). With almost 50 distinct BTB entries in publicly available sequence data bases, it is
estimated that 5 to 10% of the zinc finger proteins in man contain
these domains. The organization of the human promyelocytic leukemia
zinc finger (PLZF) protein is typical of BTB domain proteins, with a
single 120-aa BTB domain found at the N terminus of the protein,
followed by a central region of several hundred amino acids, and ending with a series of C2H2 Kruppel-type zinc
fingers. The crystal structure of the BTB domain of PLZF reveals a
tightly intertwined dimer with an extensive hydrophobic interface, in
which the central scaffolding of the domain is made up of a cluster of
-helices flanked by short
-sheets (1, 23). Many BTB
proteins are transcriptional regulators that mediate expression through
the control of chromatin conformation. The PLZF protein, for example, is a transcriptional repressor in which the BTB domain interacts with
several of the components of the histone deacetylase complex (14,
16, 24). PLZF also occurs as a fusion protein with the retinoic
acid receptor
(RAR
) in a rare t(11;17) form of acute
promyelocytic leukemia (6, 10). In this disorder, the PLZF-RAR
fusion protein may repress transcription at retinoic acid-sensitive sites through BTB-mediated recruitment of the histone deacetylase complex (14, 15, 16, 24).
A third type of extended sequence motif found in some zinc finger
transcription factors is the SCAN domain, originally identified in
ZNF174 (40). The name for this domain, also called LeR
because it is a leucine-rich region (32), was derived from
the first letters of the names of four proteins initially found to
contain this domain (SRE-ZBP, CTfin51, AW-1 [ZNF174], and Number 18 cDNA or ZnF20) (2, 13, 31, 40). The SCAN domain consists of about 80 aa, and the primary amino acid sequence of the domain is not
similar to any of the other zinc finger-associated domains.
In this report we define a function for the SCAN domain. The element is
capable of mediating association between specific members of the SCAN
domain family of zinc finger transcription factors. These findings
suggest that the SCAN domain plays an important role in controlling the
assembly of complexes that contain this newly defined subfamily of zinc
finger proteins.
 |
MATERIALS AND METHODS |
Plasmid construction.
GAL4 and VP16 fusion gene plasmids
were constructed by PCR amplification of the SCAN domains of ZNF174,
ZNF165, ZNF191, ZNF192, ZnF 20, ZnFPH, CTfin51, FPM315, and SRE-ZBP
from human genomic DNA with forward primers that contained a
BamHI site and reverse primers that contained an
XbaI site. PCR products were cloned into TA cloning vector
pCR 2.1 (Invitrogen, Carlsbad, Calif.) and then digested with
BamHI and XbaI and cloned into
BamHI-XbaI-digested expression vectors pM and
pVP16 (Clontech, Palo Alto, Calif.). The SCAN domain regions placed
into the expression vectors correspond to the following nucleotides
from deposited GenBank cDNA sequences: ZNF174, nucleotides (nt) 707 to
969; ZNF165, nt 363 to 622; ZNF191, nt 301 to 560; ZNF192, nt 318 to
384; ZnF 20, nt 120 to 371; ZnFPH, nt 32153 to 32415 (corresponds to
reported genomic sequence, cDNA sequence not available); CTfin51, nt
314 to 712; FPM315, nt 396 to 655; and SRE-ZBP, nt 2 to 180. ZNF174
SCAN domain mutants were generated by site-directed mutagenesis
(Clontech). Constructs containing the FOS and JUN leucine zippers fused
to GAL4 were fused to GAL4 and VP16 as described above. Bacterial
expression plasmids for ZNF174 wild-type SCAN domain (aa3 to 128) and
mutant SCAN domain (aa 44 plus 45 L
P) were made by inserting coding sequences in frame with the SmaI site of pGEX 2T and the
BamHI-EcoRI site of pGEX 6P (Pharmacia) respectively.
CD spectroscopy.
Circular dichroism (CD) spectra were
recorded at 25°C on an Aviv 62DS spectrometer equipped with a
thermoelectric temperature controller. Protein concentrations were
estimated by the method of Bradford with the Bio-Rad kit. Samples of
recombinant ZNF174 wild-type SCAN domain (aa 3 to 128) and mutant SCAN
domain (aa 44 plus 45 L
P) at a concentration of 5 µM were prepared
in 1 phosphate-buffered saline (PBS) (67 mM phosphate, 150 mM NaCl; pH
7.0) containing 0.2 mM dithiothreitol (DTT). Spectra representing the
average of five scans from 260 to 205 nm were measured in a 10-mm path
length cuvette by using a step size of 1 nm and a 5-s signal averaging
time. All spectra were corrected for the baseline obtained with the
buffer alone (5, 25).
Two-hybrid assay.
COS-7 cells were obtained from the
American Type Culture Collection and grown on 10-cm dishes in Dulbecco
modified Eagle medium supplemented with 10% fetal bovine serum and 2 mM glutamine. Transfections were performed by the calcium phosphate
procedure as described in the manufacturer's insert for the Mammalian
Matchmaker two-hybrid assay kit (Clontech). All transfections contained
2 µg of the GAL4×5 CAT reporter construct and 10 µg of each
expression construct to be tested. Whole-cell extracts were prepared
48 h after transfection, and 10 µl of extract was assayed for
chloramphenicol acetyltransferase (CAT) activity by the two-phase fluor
diffusion technique (36).
Immunoprecipitation assays.
In vitro transcription and
translations were performed with a TNT-coupled reticulocyte system
(Promega) with [35S]methionine (Amersham Corp.) according
to the manufacturer's instructions. For each immunoprecipitation
sample, 30 µl of protein A/G-agarose (Santa Cruz) was precleared by
mixing with 1 µg of mouse immunoglobulin G (IgG) at 4°C for 3 h. The precleared agarose was then mixed with 30 µl of bovine serum
albumin (1 mg/ml), 20 µl of AU1 antibody (BabCO), and 5 µl of
radiolabeled in vitro translation product in 400 µl of
radioimmunoprecipitation assay (RIPA) buffer (50 mM Tris-HCl, 150 mM
NaCl, 1% NP-40, 0.5% deoxycholate, 1 mM EDTA). The mixture was
incubated at 4°C overnight with gentle rotation. The next day, the
protein A/G-agarose was washed three times with cold RIPA buffer. Bound
proteins were eluted by boiling for 2 min in 1× sodium dodecyl sulfate
(SDS) loading buffer and then separated on a SDS-12% polyacrylamide
gel. After electrophoresis, the gels were soaked for 15 min in gel
drying solution (10% acetic acid, 30% methanol, 3% glycerol), dried
for 1 h at 80°C, and then autoradiographed overnight.
Bacterial expression and purification of GST fusion proteins.
Escherichia coli BL21 bacteria transformed with pGEX-ZNF174
fusion constructs were grown to an optical density at 600 nm of 0.8 to
1.2 at 30°C and then induced with 0.1 mM IPTG
(isopropyl-
-D-thiogalactopyranoside) for 1 to 2 h.
Expressed proteins were purified by affinity chromatography by using
glutathione-Sepharose columns (Pharmacia) according to the
manufacturer's instructions. Fusion proteins were cleaved from
glutathione S-transferase (GST) by using either thrombin or
PreScission protease (Pharmacia) in 1× PBS plus 1 mM DTT. The purity
of the proteins was assessed by SDS-polyacrylamide electrophoresis (PAGE).
Size exclusion chromatography.
Recombinant proteins were
concentrated by centrifugation by using a VivaSpin 5,000 concentrator
and then run over a Bio-Prep SE-100/17 size exclusion chromatography
column (8 by 300 mm; Bio-Rad) with the aid of the Biologic HR
chromatography system (Bio-Rad). Columns were run in 1× PBS plus 1 mM
DTT at a flow rate of 0.2 ml/min. Columns were calibrated under the
same conditions with protein standards from Pharmacia (RNase A,
Mr = 13,700; chymotrypsinogen A,
Mr = 25,000; ovalbumin,
Mr = 43,000; BSA,
Mr = 67,000; aldolase, Mr = 158,000).
 |
RESULTS |
The SCAN domain is a highly conserved zinc finger-associated
motif.
Since our initial description of the SCAN box in six zinc
finger transcription factors was reported (40), the number
of family members has increased substantially. By using the SCAN domain
amino acid sequence from ZNF174 to screen the GenBank database, a total
of 19 genes were identified with SCAN motifs. Alignment of the amino
acid sequences of the SCAN domains encoded by each of these genes is
presented in Fig.
1A. Many
additional EST and cosmid sequences were also found to contain SCAN
boxes (data not shown). Remarkably, all of the genes with SCAN domains
contain C2H2 zinc fingers (except for TRFA, a
partial cDNA clone for which the entire open reading frame has not yet
been reported). A recent report identified a member of the SCAN domain
family as an adipogenic cofactor bound by peroxisome
proliferator-activated receptor
(PPAR
) (5a). This
protein, termed PPAR
coactivator 2 (PGC-2), has a partial SCAN
domain with homology to the N-terminal 60 residues, and it does not
have zinc fingers.




View larger version (162K):
[in this window]
[in a new window]
|
FIG. 1.
Amino acid alignment of SCAN domains. (A) The amino acid
sequences of the SCAN domains from the following genes are aligned:
ZNF174 (GenBank accession number U31248), ZNF165 (X84801), ZNF191
(U68536, also known as ZNF24 and KOX 17 [P17028]), ZNF192 (U57796,
also known as LD5-1), ZNF193 (U62392), ZNF202 (AF027219), ZNF213
(AF017433, also known as CR53), (ZnF20 (AF011573, also known as p18
[Z21707]), ZnFPH (taken from cosmid Q25 sequence, Z68344), CTfin51
(D10630, also known as Zfp-38 [X63747] and RU49 [U41671]), FPM315
(D88827), mMZF-2 (AB007407), KIAA0427 (AB007887), TRFA (L32162, also
known as 3c3 and p20), Zfp94 (U62906), Zfp95 (U62907), Zfp96 (U62908),
Zfp-29 (X55126), and SRE-ZBP (Z11773). A consensus sequence for the
SCAN domain is presented underneath the alignment. Residues that are
invariant among all the sequences are indicated within the consensus
sequence in boldface type. Identical residues fitting the SCAN
consensus have been boxed and are shaded in dark gray, conserved amino
acid differences are indicated by light-gray shading. Putative
-helical regions are indicated (H) below the sequence. The helical
predictions were made using the Predict Protein program
(33a). (B) Unrooted phylogenetic tree relating SCAN domain
sequences. All genes shown in the alignment (Fig. 1A) were used to
calculate this tree. Amino acid sequences were aligned by using
MacVector. Alignments were loaded into CLUSTALX, which calculated an
unrooted tree and all branch lengths by using the neighbor-joining
method of Saitou and Nei, which calculates distances (percent
divergence) between all pairs of sequence from a multiple alignment and
then applies the neighbor-joining method to the distance matrix. The
resultant tree was produced in Phylip format. TreeViewPPC, version
1.5.3, was used to convert the tree into graphical format. The species
of each SCAN domain is indicated to the right of the gene name as an
"h" for human or "m" for mouse. (C) -Helical character of
the SCAN domain. CD spectra of the intact SCAN domain (aa 3 to 128) of
ZNF174 ( ) and a specifically mutated form of the intact domain in
which two conserved leucines at positions 44 and 45 are mutated to
prolines ( ). (D) Gel filtration chromatography of the ZNF174 SCAN
domain. A Bio-Rad SE-100/17 high-performance liquid chromatography
column was used to determine the oligomeric state of the SCAN domain in
67 mM phosphate, 150 mM NaCl, and 1 mM DTT at pH 7.0. Chromatograms are
plotted as the A280 versus the elution time. The
elution profile for the protein standards is indicated by a dotted
line, and the molecular masses shown are in daltons. The elution
profile for the SCAN domain is indicated by a solid line. The domain
elutes as a single species with an estimated molecular weight of
41,980, consistent with the formation of elongated dimers or globular
trimers.
|
|
The SCAN domain is always located at the amino terminus of the zinc
finger transcription factor. The degree of amino acid
identity varies
among SCAN domain sequences and ranges from as
low as 39% (comparing
Zfp-29 and ZnFPH) to as high as 85% between
KIAA0427, SRE-ZBP, and
Zfp96. Of the 80 aa that comprise the SCAN
domain, 11 are identical
among all family members and form the
basis for the consensus sequence
shown in Fig.
1A. These 11 invariant
residues include 3 conserved
prolines at positions 16, 33, and
55 (Fig.
1A). Contained in the ZNF174
SCAN domain are two protein
kinase C phosphorylation sites,
(S/T)-X-(R/K) (SFR and SSK, located
at residues 4 and 75, respectively), and one conserved casein
kinase II phosphorylation site,
(S/T)-X-X-(D/E) (SSKE located
at residue 69) (Fig.
1A).
The alignment of human and mouse SCAN domains shown in Fig.
1A was used
to generate an unrooted phylogenetic tree (Fig.
1B).
Phylogenetic tree
analysis reconstructs the history of successive
divergences which took
place during evolution by comparing the
relatedness of different
molecular sequences. The results of phylogenetic
analysis are depicted
as a hierarchical branching diagram (phylogenetic
tree), with each
branch representing a group of genes derived
from a putative single
ancestral lineage. The alignment indicates
that both orthologs (related
genes derived during speciation)
and paralogs (related genes found in
one genome) are present in
the SCAN domain
family.
Secondary structure predictions for the SCAN domain (
35)
suggest that it may form several

-helices (Fig.
1A), with the
three
conserved prolines in the consensus sequence serving to
divide the SCAN
domain into at least three predicted

-helices,
the first of which is
amphipathic (Fig.
1A and reference
40).
To test this
prediction, we analyzed a recombinant form of ZNF174
(aa 3 to 128)
containing the SCAN domain (aa 45 to 124) by CD
spectroscopy (Fig.
1C).
The characteristic dips in the far UV
CD spectrum at wavelengths of 208 and 222 nm clearly indicate
that the SCAN domain has substantial
helical character in solution
(Fig.
1C). Indeed, consideration of the
molar ellipticity at 222
nm suggests that the ZNF174 polypeptide
spanning residues 3 to
128 contains ca. 25 to 30% helix. Because the
recombinant polypeptide
spans not only the 80-residue SCAN domain (61%
predicted helical
content) but also 45 additional flanking residues not
predicted
to have helical character, the observed helicity, as measured
by CD, is consistent with that estimated based on secondary structure
prediction algorithms (
33a). We next determined whether
disruption
of the predicted central helix would abolish the

-helical
character
of the SCAN domain. When the central conserved region of the
SCAN
domain is altered by mutating two conserved leucines to prolines
at positions 44 and 45, the dip in the far UV CD spectrum at 222
nm is
lost (Fig.
1C), indicating that the helical character of
the domain is
substantially
disrupted.
Several analytical approaches were used to investigate the
oligomerization properties and stability of the isolated SCAN domain.
Size exclusion chromatography of the purified recombinant SCAN
domain
(Fig.
1D) demonstrates that the SCAN domain exists as a
stable
molecular species. A plot of the logarithm of the molecular
mass of
protein standards against the elution volume predicts
the molecular
mass of the SCAN domain is ca. 42 kDa. Since the
predicted monomer size
is ca. 14 kDa, the isolated SCAN domain
could be in either a dimeric or
trimeric state. We next performed
thermally induced unfolding,
monitored by CD spectroscopy, to
investigate the stability of the SCAN
domain. The intact SCAN
domain undergoes a single irreversible
unfolding transition, whereas
the mutant form of the SCAN domain with
the proline substitutions
does not exhibit the same sharp transition
upon heating (data
not shown). This type of irreversibility is observed
in other
multimeric proteins, in which aggregation of unfolded
molecules
interferes with refolding (
18). Collectively,
these studies
demonstrate that the SCAN domain behaves as a stable
oligomeric
species under near-physiologic
conditions.
The SCAN domain is a protein-protein interaction motif.
A
mammalian two-hybrid assay system was used to test the hypothesis that
the SCAN domain mediates protein-protein interactions (Fig.
2A). One construct (the "bait")
contains a SCAN domain fused in frame behind a GAL4 DNA-binding domain,
and the second construct (the "target") contains a SCAN domain
linked to the transcriptional activator VP16. These constructs were
cotransfected into COS-7 cells along with a promoter CAT-reporter
construct that contains five GAL4 binding sites (Fig. 2A). Expression
of the CAT reporter gene indicates there has been an interaction
between the two fusion constructs.

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 2.
The SCAN domain is a protein-protein interaction domain.
(A) Schematic diagram of the mammalian two-hybrid assay. Specific
interactions between SCAN domains from various zinc finger genes were
tested by using a mammalian two-hybrid assay system. Plasmids encoding
a SCAN domain fused with the yeast GAL4 DNA-binding domain (GAL4 BD)
and a SCAN domain fused with the herpes simplex virus VP16
transactivating region (VP16 AD) were transfected into COS-7 cells,
along with a reporter plasmid (pG5CAT) containing five consensus GAL4
binding sites and an E1b minimal promoter upstream of the CAT gene.
Measured levels of CAT activity can be correlated with the relative
affinity of an interaction between hybrid proteins. (B) The SCAN domain
of ZNF174 can interact with itself in a mammalian two-hybrid assay
system. COS cells were transfected with 2 µg of reporter construct
and 10 µg each of the indicated GAL4 BD and VP16 AD expression
plasmids. Reporter construct pE1b-CAT (lane 5) is identical to pG5-CAT
except that it lacks GAL4 binding sites. ZNF174 in either the GAL4 BD
or VP16 AD vector refers to the SCAN domain region (aa 41 to 128) of
this gene, and JUN-LZ and FOS-LZ refer to two-hybrid constructs which
contain the leucine zipper regions of these genes. CAT activity is
shown in counts per minute. (C) Specificity of SCAN-SCAN protein
interactions. The table indicates the relative amounts of CAT activity
seen when specific pairwise combinations of SCAN domains are tested for
interaction in the mammalian two-hybrid assay, normalized to
self-association of the ZNF174 SCAN domain. The results observed with
different pairs of SCAN domains are presented relative to this amount.
Results from ZNF191-GAL4 are not included here due to the endogenous
transcriptional activating activity of ZNF191 when fused to the GAL4
DNA-binding domain. Data are representative of at least three
independent experiments. Asterisks indicate that the pooled data from
these particular experiments were analyzed by the nonparametric
Wilcoxon signed rank test and found to be significantly different
(P < 0.05) from the level of activity seen with ZNF174-GAL4 and
ZNF174-VP16.
|
|
Initially, we examined the ability of each SCAN domain GAL4 fusion
protein to activate transcription of the CAT reporter plasmid
when
transfected alone. With the exception of ZNF191, none of
the SCAN-GAL4
DBD fusion proteins tested activated transcription
on their own (Fig.
2B, and data not shown). Similarly, none of
the SCAN-VP16 fusions were
capable of activating transcription
when transfected singly. In control
studies, levels of each of
the SCAN domain containing GAL4 fusions were
shown to be comparable,
and the ability of each of the fusions to bind
a GAL4 site was
similar (data not shown). Taken as a whole, the current
findings
are consistent with previous studies demonstrating that
selected
SCAN domains do not activate (or repress) transcription
(
32,
40).
To determine whether the SCAN domain self-associates, the ability of
the ZNF174 SCAN-GAL4 fusion to activate the CAT reporter
gene in the
presence of the ZNF174 SCAN-VP16 fusion was examined.
As shown in Fig.
2B, coexpression of both fusion constructs markedly
activates
transcription compared with that of the empty GAL4 and
VP16 vectors or
with each of the SCAN domain fusion constructs
alone (compare lane 4 with either lane 2 or lane 3). This activation
requires DNA binding to
the GAL4 sites, since no transcriptional
activity is observed when the
5 GAL4 binding sites are removed
from the promoter of the reporter gene
(Fig.
2B, lane
5).
Next we tested the ability of the SCAN domain from ZNF174 to interact
with the leucine zipper motifs of c-Fos and c-Jun to
determine if the
SCAN domain interacted nonspecifically with other
transcription factors
that contain amphipathic

-helices mediating
oliogmerization. While
the leucine zippers from c-Fos and c-Jun
clearly associate to activate
transcription (Fig.
2B, lanes 10
and 11), no interaction is seen when
the SCAN domain of ZNF174
is cotransfected with either of the leucine
zippers (Fig.
2B,
lanes 6 to 9). This observation indicates that there
is specificity
in the interface of the ZNF174 SCAN domain that results
in self-association.
To determine which SCAN domains have the ability to bind to one
another, pairwise combinations of nine SCAN motifs were tested
in the
mammalian two-hybrid system. The results are presented
as relative
levels of CAT activation in Fig.
2C. Several general
features of SCAN
domain interactions can be inferred. First, not
all SCAN domains are
able to self-associate; in fact, the only
two SCAN boxes that exhibit
any self-association are those from
ZNF174 and ZNF192. Second,
interactions between different SCAN
boxes are selective. For example,
ZNF174 can interact with some,
but not all, SCAN domains from other
genes. Third, given that
the magnitude of the transcriptional response
in a two-hybrid
assay system can correlate with the affinity of the two
protein
components for each other (
11,
42), the variation
between
the relative affinities of the SCAN domains is significant.
Reactions
between some pairs of SCAN domain components were found to be
orientation dependent (for example, ZNF174-GAL4 and ZnF20-VP16
interacted strongly, but no interaction was observed with the
opposite
orientation, ZNF174-VP16 and ZnF20-GAL4). This phenomenon
has been
observed for numerous protein pairs in two-hybrid systems,
although the
mechanism responsible for this directionality is
unclear
(
11).
Self-association of the SCAN domain requires the entire
domain.
Predictions of the secondary structure of the SCAN domain
suggest the presence of at least three
-helices that are separated from one another by short looped regions bounded by proline residues. Although we have no evidence that these helices exist or are stably folded, we tested whether two of them might support self-association in
isolation. However, neither a sequence spanning residues 59 to 75 nor
one from residues 80 to 98 was capable of mediating self-association in
the two-hybrid assay (Fig. 3). These
findings suggest that a complete intact SCAN domain is required to
mediate self-association.

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 3.
Structural features of the SCAN domain required for
self-association. A schematic representation of ZNF174 is shown at the
top. The regions of the SCAN domain that were cloned into GAL4 BD and
VP16 AD expression plasmids are indicated below. The first construct
contains the full-length wild-type SCAN domain. The next two constructs
represent smaller regions of the SCAN domain, with each one expressing
individual predicted -helices. The last construct contains the
full-length SCAN domain in which two conserved leucines have been
mutated to prolines. -helical regions within the SCAN domain are
indicated (H) below each construct. Relative levels of CAT activity
between pairs of the expression constructs when tested by two-hybrid
analysis are shown on the right.
|
|
We next determined whether disruption of the predicted central helix
would abolish the ability of the ZNF174 SCAN domain to
self-associate
in the two-hybrid assay. When the central conserved
region of the SCAN
domain is altered by mutating two conserved
leucines to prolines at
positions 44 and 45, the helical structure
of the domain is disrupted,
as judged by CD (Fig.
1C). When this
mutant form of the SCAN domain is
screened in the two-hybrid assay,
partners that bind to the native
domain no longer associate with
this mutant (Fig.
3). Taken together,
these findings strongly
suggest that the minimum length functional unit
is the entire
SCAN domain and that structural integrity of this domain
is required
for self-association or association with other SCAN domain
partners.
ZNF174 oligomerizes via the SCAN domain.
Immunoprecipitation
studies were performed to demonstrate that the SCAN domain is capable
of mediating protein-protein interactions in the context of a
full-length form of ZNF174. The immunoprecipitation assay involved
cotranslating tagged and nontagged proteins and then looking for an
association between the two protein forms by immunoprecipitation with
an antibody that recognizes the tag. Coprecipitation of the native
protein with the tagged form indicates an association of the two forms
of the protein.
When an AU1-tagged form of full-length ZNF174 is cotranslated with two
shorter, nontagged forms of ZNF174[1-172] and -[136-408],
only the
form containing the SCAN domain (ZNF174[1-172]) is coprecipitated
in
the presence of full-length tagged ZNF174 (Fig.
4A, lane
6).
No coprecipitation band is observed with ZNF174[136-408],
suggesting
that the SCAN domain is required for self-association (Fig.
4A,
lane 12). When tagged and nontagged forms of different sizes are
mixed together after translation, coprecipitation is inefficient,
indicating that limited exchange takes place and that the association
is kinetically stable (data not shown).



View larger version (94K):
[in this window]
[in a new window]
|
FIG. 4.
Selective oligomerization via the SCAN domain. Schematic
diagrams of the proteins generated by in vitro translation are shown on
the left side of the figure. Volumes shown in the input lane are half
the amounts used for the immunoprecipitation assays. (A) The SCAN
domain mediates self-association. Analysis of
[35S]methionine-labeled AU1 epitope-tagged full-length
ZNF174[1-408] cotranslated with [35S]methionine-labeled
nontagged shorter forms of ZNF174. Lanes 1 to 6, ZNF174[1-172]; lanes
7 to 12, ZNF174[136-408]. (B) -Helical character of the SCAN
domain is required for oligomerization.
[35S]methionine-labeled nontagged wild-type SCAN domain
and a mutant form of the SCAN domain in which leucines at positions 44 and 45 were changed to prolines (mutant L>P). Lanes 1 to 6, ZNF174[1-250, wild type]; lanes 7 to 12, ZNF174[1-250, mutant
L>P]. (C) Selective interaction of SCAN domains.
[35S]methionine-labeled nontagged heterologous SCAN
domains. Lanes 1 to 6, ZnF20[1-284]; lanes 7 to 12, ZNF191[1-140];
lanes 13 to 18, FPM315[1-129].
|
|
In a SCAN domain containing two leucine-to-proline substitutions, the

-helical structure of the domain is disrupted (Fig.
1C), and the
ability of the domain to recruit SCAN domain partners
in the mammalian
two-hybrid assay is lost (Fig.
3). When the ability
of this mutated
SCAN domain (ZNF174[1-250mutL-P]) to bind to full-length
tagged
ZNF174 is compared with the native ZNF174[1-250], no coprecipitation
band is observed with the mutant SCAN domain (Fig.
4B, lane 12),
whereas the native control coprecipitates with the full-length
tagged
form (Fig.
4B, lane
6).
We next tested by immunoprecipitation assay whether full-length ZNF174
could associate with other members of the SCAN domain
family. We chose
to look at two SCAN proteins that had previously
shown a strongly
positive interaction with ZNF174 when tested
in the mammalian
two-hybrid assay (ZnF20 and ZNF191), as well
as a third protein
(FPM315) that showed only a weak interaction
with ZNF174. When the
AU1-tagged form of full-length ZNF174 is
cotranslated with shorter,
nontagged forms of either ZNF20[1-284],
or ZNF191[1-140],
coprecipitation bands are seen (Fig.
4C, lanes
6 and 12). In contrast,
no coprecipitation band is observed when
the tagged full-length ZNF174
was cotranslated with FPM315[1-129]
(Fig.
4C, lane 18), a family
member that does not interact with
ZNF174 in the two-hybrid assay (Fig.
2C). These results demonstrate
that ZNF174 can selectively bind other
members of the SCAN family
and confirm the two-hybrid
findings.
 |
DISCUSSION |
In this study we characterized a modular structural element,
termed the SCAN domain, that occurs in members of the zinc finger family of transcription factors. This highly conserved 80-aa element is
found in a rapidly expanding family of zinc finger proteins. The SCAN
domain appears to control association of SCAN domain proteins into
noncovalent, multisubunit complexes and may be the primary mechanism
underlying partner choice in the oligomerization of these zinc finger
transcription factors.
Since this is a newly identified subgroup of zinc finger proteins, we
know remarkably little about the SCAN domain-containing proteins and
their functions. A summary of what is known about the SCAN family
members is presented in Table 1. Many of
the SCAN domain family members appear to be clustered together in specific chromosomal regions (Table 1). The genes located on chromosomes 3p21, 6p21.3, 11p15.5, and 16p13.3 are of particular interest because these locations are frequently disrupted in a variety
of cytogenetic abnormalities. Several SCAN domain genes were cloned as
a result of attempts to identify candidate disease genes that lie
within these chromosomal regions. The clustered organization of genes
for other zinc finger proteins has been reported from the analysis of
human and mouse chromosomes (17), but a correlation between
genomic organization and expression characteristics has not been
established.
Several of the SCAN domain-containing genes are expressed at high
levels in the testis and/or ovary (Table 1). Three genes, ZNF165,
ZNF202, and Zfp-29, are expressed exclusively in the testis (9,
22, 28, 38). Studies with Zfp-29 and another SCAN family member,
CTfin51, suggest that these genes may play a role in the regulation of
spermatogenesis (7, 9, 31). CTfin51 (Zipro1, Ru49, or Zfp38)
may also be important in lineage determination. In the cerebellar
cortex, this SCAN box family member is a marker for the cerebellar
granule neuronal lineage and may play a role in the proliferation of
granule cell precursors in the developing cerebellum (42a,
43). Additionally, the gene is expressed in skin and increased
dosage results in a hair loss phenotype associated with increased
epithelial cell proliferation and abnormal hair follicle development
(42a). Collectively, these studies suggest that this family
of transcription factors may perform a wide range of functions
important in human cell differentiation or development.
The SCAN domain-containing zinc finger proteins can either activate or
repress transcription, although recombinant SCAN boxes in isolation
generally do not affect transcription. CTfin51 and myeloid zinc finger
protein-2 (MZF-2) are both transcriptional activators that contain
functional transactivation domains (Table 1). The structure of the
activation domains and the potential role of coactivators in increasing
transcription are not well understood. At least four of the SCAN domain
family members also contain KRAB domains, suggesting that they may
function as transcriptional repressors (Table 1). ZNF174 does not
contain a consensus KRAB element but has been previously shown to be
capable of repressing expression of a promoter-reporter CAT plasmid
(40). This raises the possibility that ZNF174 contains a
novel repression domain capable of interacting with corepressors to
decrease gene expression. Little is known about the authentic DNA
binding sites or the target genes that are controlled by the SCAN
family members.
The phylogenetic tree analysis presented in Fig. 1B was constructed by
using all of the SCAN domains from the genes in Table 1, so it includes
both human and mouse genes. It is possible that some of the pairings in
the tree represent human and mouse homologs or orthologs (CTfin51 with
ZNF165 and KIAA0427 with Zfp96, for example). Although the SCAN domains
of these genes are quite similar, there is not a lot of sequence
homology between these genes outside of the SCAN domain. There are
several possible reasons for the sequence differences outside the SCAN
domain. First, the genes are not orthologs. Second, these regions could
have diverged after a speciation event. Finally, new sequences could
have entered into the family by gene rearrangement. There is no strong
correlation between the ability of two SCAN domains to interact with
each other and their position in the tree. There are, however, several examples of SCAN domains from genes found on the same chromosome that
have been paired together on the tree, suggesting that these genes may
have arisen by gene duplication. Examples include TRFA and ZNF20 on
chromosome 3, ZNF174 and ZNF213 on chromosome 16p13.3, and ZNF192 and
ZNF193 on chromosome 6 (Fig. 1B and Table 1). Interestingly, the SCAN
domain from ZNF191 is not clustered with any of the other SCAN domains
on the phylogenetic tree. It is also the only SCAN domain that has the
ability to activate transcription, so it has clearly diverged from the
other SCAN sequences to acquire these characteristics.
Multiple mechanisms may regulate the function of the SCAN domain.
First, the domain could be removed by differential mRNA splicing or by
specific proteolysis. The human MZF-2 gene has been found to generate
two different mRNA transcripts through the alternative use of two
transcription initiation sites (29, 30). The longer form
contains the SCAN domain, while the shorter form lacks sequence
encoding the SCAN domain. Smaller transcript forms of ZNF174, ZNF202,
FPM315, ZnF20, and ZnFPH have been detected by Northern blot
(references 13, 28, 40, and 44
and unpublished observations), suggesting that these genes may also
utilize alternative start sites and/or alternative exon splicing to
produce molecules that contain the zinc finger DNA binding regions but
lack SCAN domains. Second, the function of the domain could be
regulated by covalent modifications such as phosphorylation. All but
three of the SCAN domain sequences presented in Fig. 1A contain a
potential casein kinase II phosphorylation site [(S/T)XX(D/E)] at
residues 69 to 72. Phosphorylation (or dephosphorylation) events may
regulate the protein-protein interactions or DNA binding. Third, SCAN
domain activity could be controlled by interaction with proteins that contain the domain. The amino-terminal location of the SCAN domain may
facilitate oligomerization. The ability of the domain to participate in
heteromeric interactions with other SCAN family members suggests that
it should be possible to map residues that determine the specificity of
SCAN domain interactions. A hierarchy of affinities between these
domains would allow for selective pairing of members of the family.
Different combinations of transcription factor partners could create
new molecules with altered binding recognition sites and regulatory
functions (21). The regulated association of distinct
members of a transcription factor family is well illustrated by the
differential dimerization of Myc, Max, and Mad (8). Increased expression of Myc is associated with increased cellular proliferation, while in the absence of Myc, Max-Max homodimers and
Max-Mad heterodimers repress transcription from growth-regulatory genes. Another example of this type of regulation involves MyoD, a
basic DNA-binding domain, helix-loop-helix transcriptional activator of
numerous muscle specific genes (34). MyoD function is
controlled by Id which, like MyoD, contains a helix-loop-helix motif,
but which lacks the basic domain required for DNA binding. During muscle cell differentiation, levels of Id fall, releasing another helix-loop-helix protein (E12 or E47) which dimerizes with MyoD and
activates gene expression. Fourth, SCAN domain activity could also be
controlled by interaction with proteins that lack the motif. These
examples illustrate the diverse mechanisms that might regulate the
transcriptional activity of members of the SCAN family of transcription
factors. In summary, the current studies provide the first description
of the function of the SCAN domain and may provide insights into the
interactions among the members of this new group of transcription factors.
 |
ACKNOWLEDGMENTS |
We thank Michelle Spotnitz for assistance with the calculation of
the phylogenetic tree.
These studies were supported by NIH grants R37 HL35716 and HL61001.
S.C.B. is a Pew Scholar in the Biomedical Sciences.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Brigham and
Women's Hospital, Vascular Research Division, 221 Longwood Ave.,
Boston, MA 02115. Phone: (617) 732-5990. Fax: (617) 278-6990. E-mail: tcollins{at}bustoff.bwh.harvard.edu.
 |
REFERENCES |
| 1.
|
Ahmad, K. F.,
C. K. Engel, and G. G. Prive.
1998.
Crystal structure of the BTB domain from PLZF.
Proc. Natl. Acad. Sci. USA
95:12123-12128[Abstract/Free Full Text].
|
| 2.
|
Attar, R. M., and M. Z. Gilman.
1992.
Expression cloning of a novel zinc finger protein that binds to the c-fos serum response element.
Mol. Cell. Biol.
12:2432-2443[Abstract/Free Full Text].
|
| 3.
|
Bardwell, V. J., and R. Treisman.
1994.
The POZ domain: a conserved protein-protein interaction motif.
Genes Dev.
8:1664-1677[Abstract/Free Full Text].
|
| 4.
|
Bellefroid, E. J.,
D. A. Poncelet,
P. J. Lecocq,
O. Revelant, and J. A. Martial.
1991.
The evolutionarily conserved Kruppel-associated box domain defines a subfamily of eukaryotic multifingered proteins.
Proc. Natl. Acad. Sci. USA
88:3608-3612[Abstract/Free Full Text].
|
| 5.
|
Blacklow, S. C.,
M. Lu, and P. S. Kim.
1995.
A trimeric subdomain of the simian immunodeficiency virus envelope glycoprotein.
Biochemistry
34:14955-14962[Medline].
|
| 5a.
|
Castillo, G.,
R. P. Brun,
J. K. Rosenfield,
S. Hauser,
C. W. Park,
A. E. Troy,
M. E. Wright, and B. M. Spiegelman.
1999.
An adipogenic cofactor bound by the differentiation domain of PPAR .
EMBO J.
18:3676-3687[Medline].
|
| 6.
|
Chen, Z.,
N. J. Brand,
A. Chen,
S. J. Chen,
J. H. Tong,
Z. Y. Wang,
S. Waxman, and A. Zelent.
1993.
Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid receptor alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukemia.
EMBO J.
12:1161-1167[Medline].
|
| 7.
|
Chowhurdy, K.,
M. Goulding,
C. Walther,
K. Imai, and H. Fickenscher.
1992.
The ubiquitous transactivator Zfp-38 is upregulated during spermatogenesis with differential transcription.
Mech. Dev.
39:129-142[Medline].
|
| 8.
|
Dang, C. V.
1999.
c-Myc target genes involved in cell growth, apoptosis, and metabolism.
Mol. Cell. Biol.
19:1-11[Free Full Text].
|
| 9.
|
Denny, P., and A. Ashworth.
1991.
A zinc finger protein-encoding gene expressed in the post-meiotic phase of spermatogenesis.
Gene
106:221-227[Medline].
|
| 10.
|
Dong, S.,
J. Zhu,
A. Reid,
P. Strutt,
F. Guidez,
H. J. Zhong,
Z. Y. Wang,
J. Licht,
S. Waxman,
C. Chomienne,
Z. Chen,
A. Zelent, and S. J. Chen.
1996.
Amino-terminal protein-protein interaction motif (POZ-domain) is responsible for activities of the promyelocytic leukemia zinc finger-retinoic acid receptor- fusion protein.
Proc. Natl. Acad. Sci. USA
93:3624-3629[Abstract/Free Full Text].
|
| 11.
|
Estojak, J.,
R. Brent, and E. A. Golemis.
1995.
Correlation of two-hybrid affinity data with in vitro measurements.
Mol. Cell. Biol.
15:5820-5829[Abstract].
|
| 12.
|
Friedman, J. R.,
W. J. Fredericks,
D. E. Jensen,
D. W. Speicher,
X. P. Huang,
E. G. Neilson, and F. J. Rauscher, III.
1996.
KAP-1, a novel corepressor for the highly conserved KRAB repression domain.
Genes Dev.
10:2067-2078[Abstract/Free Full Text].
|
| 13.
|
Gonsky, R.,
J. A. Knauf,
R. Elisei,
J. W. Wang,
S. Su, and J. A. Fagin.
1997.
Identification of rapid turnover transcripts overexpressed in thyroid tumors and thyroid cancer cell lines: use of a targeted differential RNA display method to select for mRNA subsets.
Nucleic Acids Res.
25:3823-3831[Abstract/Free Full Text].
|
| 14.
|
Guidez, F.,
S. Ivins,
J. Zhu,
M. Soderstrom,
S. Waxman, and A. Zelent.
1998.
Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia.
Blood
91:2634-2642[Abstract/Free Full Text].
|
| 15.
|
He, L. Z.,
F. Guidez,
C. Tribioli,
D. Peruzzi,
M. Ruthardt,
A. Zelent, and P. P. Pandolfi.
1998.
Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.
Nat. Genet.
18:126-135[Medline].
|
| 16.
|
Hong, S. H.,
G. David,
C. W. Wong,
A. Dejean, and M. L. Privalsky.
1997.
SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARalpha) and PLZF-RARalpha oncoproteins associated with acute promyelocytic leukemia.
Proc. Natl. Acad. Sci. USA
94:9028-9033[Abstract/Free Full Text].
|
| 17.
|
Hoovers, J. M.,
M. Mannens,
R. John,
J. Bliek,
V. van Heyningen,
D. J. Porteous,
N. J. Leschot,
A. Westerveld, and P. F. Little.
1992.
High-resolution localization of 69 potential human zinc finger protein genes: a number are clustered.
Genomics
2:254-263.
|
| 18.
|
Jaenicke, R., and R. Rudolph.
1986.
Refolding and association of oligomeric proteins.
Methods Enzymol.
131:218-250[Medline].
|
| 19.
|
Kim, S. S.,
Y. M. Chen,
E. O'Leary,
R. Witzgall,
M. Vidal, and J. V. Bonventre.
1996.
A novel member of the RING finger family, KRIP-1, associates with the KRAB-A transcriptional repressor domain of zinc finger proteins.
Proc. Natl. Acad. Sci. USA
93:15299-15304[Abstract/Free Full Text].
|
| 20.
|
Klug, A., and J. W. R. Schwabe.
1995.
Zinc fingers.
FASEB J.
9:597-604[Abstract].
|
| 21.
|
Lamb, P., and S. L. McKnight.
1991.
Diversity and specificity in transcriptional regulation: the benefits of heterotypic dimerization.
Trends Biochem. Sci.
16:417-422[Medline].
|
| 22.
|
Lee, P. L.,
T. Gelbart,
C. West,
M. Adams,
R. Blackstone, and E. Beutler.
1997.
Three genes encoding zinc finger proteins on human chromosome 6p21.3: Members of a new subclass of the kruppel gene family containing the conserved SCAN box domain.
Genomics
43:191-201[Medline].
|
| 23.
|
Li, X.,
J. M. Lopez-Guisa,
N. Ninan,
E. J. Weiner,
F. J. Rauscher III, and R. Marmorstein.
1997.
Overexpression, purification, characterization, and crystallization of the BTB/POZ domain from the PLZF oncoprotein.
J. Biol. Chem.
272:27324-27329[Abstract/Free Full Text].
|
| 24.
|
Lin, R. J.,
L. Nagy,
S. Inoue,
W. Shao,
W. H. Miller, Jr., and R. M. Evans.
1998.
Role of the histone deacetylase complex in acute promyelocytic leukaemia.
Nature
391:811-814[Medline].
|
| 25.
|
Lu, M.,
S. C. Blacklow, and P. S. Kim.
1995.
A trimeric structural domain of the human immunodeficiency virus type-1 transmembrane glycoprotein.
Nat. Struct. Biol.
2:1075-1082[Medline].
|
| 26.
|
Margolin, J. F.,
J. R. Friedman,
W. K. Meyer,
H. Vissing,
H. J. Theisen, and F. J. Rauscher, III.
1994.
Kruppel-associated boxes are potent transcriptional repression domains.
Proc. Natl. Acad. Sci. USA
91:4509-4513[Abstract/Free Full Text].
|
| 27.
|
McKnight, S. L.
1996.
Transcription revisited: a commentary on the 1995 Cold Spring Harbor Laboratory meeting. Mechanisms of eukaryotic transcription.
Genes Dev.
10:367-381[Free Full Text].
|
| 28.
|
Monaco, C.,
M. H. Citterich,
E. Caprini,
I. Vorechovsky,
G. Russo,
C. M. Croce,
G. Barbanti-Brodano, and M. Negrini.
1998.
Molecular cloning and characterization of ZNF202: A new gene at 11q23.3 encoding testis-specific zinc finger proteins.
Genomics
52:358-362[Medline].
|
| 29.
|
Murai, K.,
H. Murakami, and S. Nagata.
1997.
A novel form of the myeloid-specific zinc finger protein (MZF-2).
Genes Cells
2:581-591[Abstract].
|
| 30.
|
Murai, K.,
H. Murakami, and S. Nagata.
1998.
Myeloid specific transcriptional activation by murine myeloid zinc finger protein 2.
Proc. Natl. Acad. Sci. USA
95:3461-3466[Abstract/Free Full Text].
|
| 31.
|
Noce, T.,
Y. Fujiwara,
M. Sezaki,
H. Fujimoto, and T. Higashinakagawa.
1992.
Expression of a mouse zinc finger protein in both spermatocytes and oocytes during meiosis.
Dev. Biol.
153:356-367[Medline].
|
| 32.
|
Pengue, G.,
V. Calabro,
P. Cannada-Bartoli,
A. Pagliuca, and L. Lania.
1994.
Repression of transcriptional activity at a distance by the evolutionarily conserved KRAB domain present in a subfamily of zinc finger proteins.
Nucleic Acids Res.
22:2908-2914[Abstract/Free Full Text].
|
| 33.
|
Peteranderl, R.,
M. Rabenstein,
Y.-K. Shin,
C. W. Liu,
D. E. Wemmer,
D. S. King, and H. C. M. Nelson.
1999.
Biochemical and biophysical characterization of the trimerization domain from the heat shock transcription factor.
Biochemistry
38:3558-3569.
|
| 33a.
| Predict Protein program. 1999, copyright date.
[Online.] http://dodo.cpmc.columbia.edu/predictprotein. [6 May 1999, last date accessed.]
|
| 34.
|
Rawls, A., and E. N. Olson.
1997.
MyoD meets its maker.
Cell
89:5-8[Medline].
|
| 35.
|
Rost, B., and C. Sander.
1993.
Improved prediction of protein secondary structure by use of sequence profiles and neural networks.
Proc. Natl. Acad. Sci. USA
90:7558-7562[Abstract/Free Full Text].
|
| 36.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Plainview, N.Y
|
| 37.
|
Tjian, R., and T. Maniatis.
1994.
Transcriptional activation: a complex puzzle with few easy pieces.
Cell
77:5-8[Medline].
|
| 38.
|
Tirosvoutis, K. N.,
A. Divane,
M. Jones, and N. A. Affara.
1995.
Characterization of a novel zinc finger gene (ZNF165) mapping to 6p21 that is expressed specifically in testis.
Genomics
28:485-490[Medline].
|
| 39.
|
Vissing, H.,
W. K. Meyer,
L. Aagard,
N. Tommerup, and H. J. Thiesen.
1995.
Repression of transcriptional activity by heterologous KRAB domains present in zinc finger proteins.
FEBS Lett.
369:153-157[Medline].
|
| 40.
|
Williams, A. J.,
L. M. Khachigian, and T. Collins.
1995.
Isolation and characterization of a novel zinc-finger protein with transcriptional repressor activity.
J. Biol. Chem.
270:22143-22152[Abstract/Free Full Text].
|
| 41.
|
Witzgall, R.,
E. O'Leary,
A. Leaf,
D. Onaldi, and J. V. Bonventre.
1994.
The Kruppel-associated box-A (KRAB-A) domain of zinc finger proteins mediates transcriptional repression.
Proc. Natl. Acad. Sci. USA
91:4514-4518[Abstract/Free Full Text].
|
| 42.
|
Yang, M.,
Z. Wu, and S. Fields.
1995.
Protein-peptide interactions analyzed with the yeast two-hybrid system.
Nucleic Acids Res.
23:1152-1156[Abstract/Free Full Text].
|
| 42a.
|
Yang, X. W.,
C. Wynder,
M. L. Doughty, and N. Heintz.
1999.
BAC-mediated gene-dosage analysis reveals a role for Zipro1 (Ru49/Zfp38) in progenitor cell proliferation in cerebellum and skin.
Nat. Genet.
22:327-335[Medline].
|
| 43.
|
Yang, X. W.,
R. Zhong, and N. Heintz.
1996.
Granule cell specification in the developing mouse brain as defined by expression of the zinc finger transcription factor RU49.
Development
122:555-566[Abstract].
|
| 44.
|
Yokoyama, M.,
M. Nakamura,
K. Okubo,
K. Matsubara,
Y. Nishi,
T. Matsumoto, and A. Fukushima.
1997.
Isolation of a cDNA encoding a widely expressed novel zinc finger protein with the LeR and KRAB-A domains.
Biochim. Biophys. Acta
1353:13-17[Medline].
|
Molecular and Cellular Biology, December 1999, p. 8526-8535, Vol. 19, No. 12
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Storm, M. P., Kumpfmueller, B., Thompson, B., Kolde, R., Vilo, J., Hummel, O., Schulz, H., Welham, M. J.
(2009). Characterization of the Phosphoinositide 3-Kinase-Dependent Transcriptome in Murine Embryonic Stem Cells: Identification of Novel Regulators of Pluripotency. Stem Cells
27: 764-775
[Abstract]
[Full Text]
-
Ecker, K., Lorenz, A., Wolf, F., Ploner, C., Bock, G., Duncan, T., Geley, S., Helmberg, A.
(2009). A RAS recruitment screen identifies ZKSCAN4 as a glucocorticoid receptor-interacting protein. J Mol Endocrinol
42: 105-117
[Abstract]
[Full Text]
-
Harper, J., Yan, L., Loureiro, R. M., Wu, I., Fang, J., D'Amore, P. A., Moses, M. A.
(2007). Repression of Vascular Endothelial Growth Factor Expression by the Zinc Finger Transcription Factor ZNF24. Cancer Res.
67: 8736-8741
[Abstract]
[Full Text]
-
Zhang, W., Walker, E., Tamplin, O. J., Rossant, J., Stanford, W. L., Hughes, T. R.
(2006). Zfp206 regulates ES cell gene expression and differentiation. Nucleic Acids Res
34: 4780-4790
[Abstract]
[Full Text]
-
Huntley, S., Baggott, D. M., Hamilton, A. T., Tran-Gyamfi, M., Yang, S., Kim, J., Gordon, L., Branscomb, E., Stubbs, L.
(2006). A comprehensive catalog of human KRAB-associated zinc finger genes: Insights into the evolutionary history of a large family of transcriptional repressors. Genome Res
16: 669-677
[Abstract]
[Full Text]
-
Ogawa, H., Murayama, A., Nagata, S., Fukunaga, R.
(2003). Regulation of Myeloid Zinc Finger Protein 2A Transactivation Activity through Phosphorylation by Mitogen-activated Protein Kinases. J. Biol. Chem.
278: 2921-2927
[Abstract]
[Full Text]
-
Looman, C., Abrink, M., Mark, C., Hellman, L.
(2002). KRAB Zinc Finger Proteins: An Analysis of the Molecular Mechanisms Governing Their Increase in Numbers and Complexity During Evolution. Mol Biol Evol
19: 2118-2130
[Abstract]
[Full Text]
-
Stone, J. R., Maki, J. L., Blacklow, S. C., Collins, T.
(2002). The SCAN Domain of ZNF174 Is a Dimer. J. Biol. Chem.
277: 5448-5452
[Abstract]
[Full Text]
-
Albanese, V., Biguet, N. F., Kiefer, H., Bayard, E., Mallet, J., Meloni, R.
(2001). Quantitative effects on gene silencing by allelic variation at a tetranucleotide microsatellite. Hum Mol Genet
10: 1785-1792
[Abstract]
[Full Text]
-
Collins, T., Stone, J. R., Williams, A. J.
(2001). All in the Family: the BTB/POZ, KRAB, and SCAN Domains. Mol. Cell. Biol.
21: 3609-3615
[Full Text]
-
Sander, T. L., Haas, A. L., Peterson, M. J., Morris, J. F.
(2000). Identification of a Novel SCAN Box-related Protein That Interacts with MZF1B. THE LEUCINE-RICH SCAN BOX MEDIATES HETERO- AND HOMOPROTEIN ASSOCIATIONS. J. Biol. Chem.
275: 12857-12867
[Abstract]
[Full Text]
-
Schumacher, C., Wang, H., Honer, C., Ding, W., Koehn, J., Lawrence, Q., Coulis, C. M., Wang, L. L., Ballinger, D., Bowen, B. R., Wagner, S.
(2000). The SCAN Domain Mediates Selective Oligomerization. J. Biol. Chem.
275: 17173-17179
[Abstract]
[Full Text]
-
Kanaya, E., Watanabe, K., Nakajima, N., Okada, K., Shimura, Y.
(2001). Zinc Release from the CH2C6 Zinc Finger Domain of FILAMENTOUS FLOWER Protein from Arabidopsis thaliana Induces Self-assembly. J. Biol. Chem.
276: 7383-7390
[Abstract]
[Full Text]